Related Experiment Video
Updated: Jun 5, 2026
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
HeartWare third-generation implantable continuous flow pump as biventricular support: mid-term follow-up
Antonio Loforte1, Paola Lilla Della Monica, Andrea Montalto
1Department of Cardiac Surgery and Transplantation, San Camillo Hospital, P.za C. Forlanini n. 1, 00151 Rome, Italy. antonioloforte@yahoo.it
Interactive Cardiovascular and Thoracic Surgery
|December 22, 2010
Summary
A HeartWare HVAD pump provided long-term mechanical biventricular support for end-stage heart failure in a Korean patient with a small chest. Early to mid-term results show successful ventricular support.
Area of Science:
- Cardiology
- Medical Devices
- Mechanical Circulatory Support
Background:
- Idiopathic dilative cardiomyopathy can lead to refractory end-stage heart failure.
- Mechanical biventricular support offers a treatment option for advanced heart failure.
- Patient selection is crucial for successful implantation, especially in cases with small chest sizes.
Observation:
- A HeartWare HVAD (HeartWare, Inc, USA) third-generation continuous flow pump was implanted for biventricular support.
- The patient was Korean with a small chest size, presenting with refractory end-stage heart failure.
- The implantation aimed for long-term mechanical circulatory support.
Findings:
- The HeartWare HVAD system was successfully implanted in a patient with a small chest.
- Early to mid-term follow-up data was collected to assess the device's performance.
- The continuous flow pump provided mechanical biventricular support.
Implications:
- This case demonstrates the feasibility of using HeartWare HVAD in patients with specific anatomical challenges.
- Successful long-term mechanical support can improve outcomes for end-stage heart failure patients.
- Further studies on device performance in diverse patient populations are warranted.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...